03/06/2024  16:10:58 Diferencia -3.50 Volumen Bid- Ask03/06/2024 Capitalización de mecado Dividendo A. P/E Ratio
41.27USD -7.82% 103,611
Volumen de negocios: 4.29 millones
-Volumen de oferta: - 41.33Tamaño/ Volumen/ Formato de Ask: 212 74.42 mil millonesUSD - -

Descripción de negocio

GSK is a british pharmaceutical and healthcare company. GSK manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions. Many medicines were historically discovered or developed at GSK and its predecessor companies and are now sold as generics.
 

Consejo de gestión & Consejo de supervisión

CEO
Emma Walmsley
Consejo de gestión
Julie Brown, Diana Conrad, James Ford, Luke Miels, Sally Jackson, Tony Wood, Shobie Ramakrishnan, David Redfern, Regis Simard, Phil Thomson, Deborah Waterhouse
Consejo de supervisión
Jonathan Symonds, Emma Walmsley, Iain Mackay, Elizabeth (Liz) McKee Anderson, Charles Bancroft, Dr. Hal Barron, Dr. Anne Beal, Dr. Harry (Hal) C Dietz, Dr. Jesse Goodman, Urs Rohner, Dr. Vishal Sikka, Wendy Becker, Dr. Jeannie Lee
 

Datos de la empresa

Nombre: GlaxoSmithKline PLC
Dirección: 980 Great West Road,UK-Brentford, Middlesex TW8 9GS
Teléfono: +44-20-8047-5000
Fax: -
E-mail: -
Internet: www.gsk.com
Industria: Healthcare
Sector: Pharmaceutical Industry
Subsector: Pharmaceuticals
Fin del año financiero: 31/12
Acciones de libre circulación: 41.74%
Fecha de OPI: -

Relación con inversores

Nombre: Nick Stone
IR teléfono: +44 7717 618834
IR-fax: -
IR e-mail: GSK.Investor-Relations@gsk.com

Calendario de la empresa

CW 28 | 11/07/2024 Dividend Payment
CW 31 | 31/07/2024 Interim Report 2nd Quarter/6 Months
CW 44 | 30/10/2024 Interim Report 3rd Quarter/9 Months
CW 6 | 05/02/2025 Report 4th Quarter
 

Accionistas mayoritarios